To manage the respiratory distress, skin issues, visual impairments, and mental challenges presented by the newborn., the decision was made to admit the baby to the Neonatal Intensive Care Unit (NICU) for specialized care(figure 2,3). The baby was placed in a temperature-controlled incubator within this unit to provide the optimal environment for their recovery and well-being.
A comprehensive regimen of medications and therapies was established for the baby’s treatment. To alleviate the breathing difficulties, the baby was administered gentamicin and ampicillin intramuscularly to combat potential infections. The skin conditions were treated with a combination of topical medications, including an emulsion of RDen, mupirocin ointment, Lubratax ointment, erythromycin ointment, and gentamicin eye ointment. These treatments aim to alleviate skin issues and promote healing.
In addition to these measures, meticulous eye care was essential due to visual impairments. Gentamicin eye ointment and injections managed potential eye infections and protected the baby’s delicate eyesight.
Furthermore, a portable brain ultrasound on the newborn revealed no evident signs of hydrocephalus or midline shift, providing some relief from concerns related to these conditions. There were no indications of intraventricular hemorrhage (IVH) or cerebral parenchymal lesions, underscoring the importance of early monitoring and intervention to safeguard the baby’s neurological health. The multidisciplinary approach in the NICU, combining respiratory support, dermatological care, eye treatments, and neurological assessments, aimed to provide the newborn with the best possible care and enhance their prospects for a healthy future. Close monitoring and tailored interventions will continue to be essential to the baby’s ongoing care and treatment plan.
Despite all efforts for further investigations and actions to treat the patient, the baby’s family finally discharged the baby from the hospital with personal consent.
Discussion :